$ACAN
AmeriCann, Inc.

2023 Q2 Form 10-Q Financial Statement

#000143774923013846 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $582.9K $748.4K
YoY Change -26.93% 12.14%
Cost Of Revenue $0.00 $0.00
YoY Change -100.0% -100.0%
Gross Profit $582.9K $748.4K
YoY Change -25.82% 13.94%
Gross Profit Margin 100.0% 100.0%
Selling, General & Admin $454.2K $479.3K
YoY Change -1.11% 1.59%
% of Gross Profit 77.93% 64.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $115.6K $113.3K
YoY Change 2.75% 0.74%
% of Gross Profit 19.83% 15.14%
Operating Expenses $454.2K $479.2K
YoY Change -1.11% 1.59%
Operating Profit $128.7K $269.2K
YoY Change -60.58% 45.4%
Interest Expense -$184.6K -$182.5K
YoY Change 12.77% 13.46%
% of Operating Profit -143.46% -67.82%
Other Income/Expense, Net -$184.6K -$182.5K
YoY Change 12.78% 13.46%
Pretax Income -$55.93K $86.62K
YoY Change -134.37% 257.34%
Income Tax
% Of Pretax Income
Net Earnings -$55.93K $86.62K
YoY Change -134.37% 257.35%
Net Earnings / Revenue -9.59% 11.57%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 24.39M 24.39M
Diluted Shares Outstanding 24.39M 24.39M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.392M $1.253M
YoY Change 41.25% 53.75%
Cash & Equivalents $1.392M $1.253M
Short-Term Investments
Other Short-Term Assets $33.30K $43.30K
YoY Change -58.24% 0.0%
Inventory
Prepaid Expenses
Receivables $21.47K
Other Receivables $267.7K
Total Short-Term Assets $1.654M $1.585M
YoY Change 17.32% 38.6%
LONG-TERM ASSETS
Property, Plant & Equipment $13.61M $13.70M
YoY Change -1.59% -1.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $13.61M $13.70M
YoY Change -1.64% -1.56%
TOTAL ASSETS
Total Short-Term Assets $1.654M $1.585M
Total Long-Term Assets $13.61M $13.70M
Total Assets $15.27M $15.29M
YoY Change 0.11% 1.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $79.68K $85.19K
YoY Change -3.42% 3.26%
Accrued Expenses $52.65K $53.78K
YoY Change -21.01% -11.0%
Deferred Revenue
YoY Change
Short-Term Debt $4.484M $4.435M
YoY Change 2889.18% 2856.71%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.624M $4.583M
YoY Change 801.33% 799.66%
LONG-TERM LIABILITIES
Long-Term Debt $581.7K $581.7K
YoY Change -88.11% -88.04%
Other Long-Term Liabilities $4.208M $4.211M
YoY Change -0.28% -0.28%
Total Long-Term Liabilities $4.789M $4.792M
YoY Change -47.43% -47.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.624M $4.583M
Total Long-Term Liabilities $4.789M $4.792M
Total Liabilities $9.413M $9.375M
YoY Change -2.18% -2.3%
SHAREHOLDERS EQUITY
Retained Earnings -$19.71M -$19.65M
YoY Change -1.14% -2.21%
Common Stock $2.439K $2.439K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.856M $5.911M
YoY Change
Total Liabilities & Shareholders Equity $15.27M $15.29M
YoY Change 0.11% 1.49%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$55.93K $86.62K
YoY Change -134.37% 257.35%
Depreciation, Depletion And Amortization $115.6K $113.3K
YoY Change 2.75% 0.74%
Cash From Operating Activities $172.9K $161.5K
YoY Change -24.64% 24.42%
INVESTING ACTIVITIES
Capital Expenditures $46.46K $192.0K
YoY Change -170.58% -391.0%
Acquisitions
YoY Change
Other Investing Activities $12.69K $10.12K
YoY Change 80.51% -0.2%
Cash From Investing Activities -$33.77K -$181.9K
YoY Change -42.58% 225.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 172.9K 161.5K
Cash From Investing Activities -33.77K -181.9K
Cash From Financing Activities 0.000 0.000
Net Change In Cash 139.1K -20.45K
YoY Change -18.45% -127.66%
FREE CASH FLOW
Cash From Operating Activities $172.9K $161.5K
Capital Expenditures $46.46K $192.0K
Free Cash Flow $126.4K -$30.57K
YoY Change -57.18% -115.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Income Loss
NetIncomeLoss
-508788 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
86622 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001508348
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6743575 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6778085 usd
CY2023Q1 us-gaap Assets
Assets
15286718 usd
CY2022Q3 us-gaap Assets
Assets
15437530 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
85188 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
193170 usd
CY2023Q1 acan Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
0 usd
CY2022Q3 acan Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
4303 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
42042 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
53964 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8957 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8612 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11735 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11283 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
69491 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
162353 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
4435059 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
4337647 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4582981 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4837176 usd
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24391961
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24391961
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24391961
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24391961
acan Operating Lease Lease Income Related Party
OperatingLeaseLeaseIncomeRelatedParty
0 usd
acan Operating Lease Lease Income Related Party
OperatingLeaseLeaseIncomeRelatedParty
407264 usd
CY2023Q1 acan Operating Lease Lease Income Related Party
OperatingLeaseLeaseIncomeRelatedParty
0 usd
CY2022Q1 acan Operating Lease Lease Income Related Party
OperatingLeaseLeaseIncomeRelatedParty
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
21950 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
10500 usd
us-gaap Gross Profit
GrossProfit
1469557 usd
us-gaap Gross Profit
GrossProfit
1296361 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
748406 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
656866 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
5371 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
23138 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3953 usd
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
10171 usd
us-gaap Professional Fees
ProfessionalFees
203852 usd
us-gaap Professional Fees
ProfessionalFees
211236 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
83339 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
86177 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
783263 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1245489 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
391957 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
375401 usd
us-gaap Operating Expenses
OperatingExpenses
992486 usd
us-gaap Operating Expenses
OperatingExpenses
1479863 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
269157 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
185117 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
2796 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
6680 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1133 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3119 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-367704 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-325286 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-182535 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-160877 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
24240 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24304886
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
5510410 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-533028 usd
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
90000 usd
CY2021Q4 acan Warrants Extension
WarrantsExtension
374946 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5442328 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
5466568 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5802112 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
22745 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5824857 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
86622 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5911479 usd
us-gaap Net Income Loss
NetIncomeLoss
-508788 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
225794 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
224961 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
34510 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
34093 usd
acan Share Based Compensation And Fair Value Adjustment Of Warrants Expense
ShareBasedCompensationAndFairValueAdjustmentOfWarrantsExpense
0 usd
acan Share Based Compensation And Fair Value Adjustment Of Warrants Expense
ShareBasedCompensationAndFairValueAdjustmentOfWarrantsExpense
374946 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
90000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
97412 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
51953 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-29433 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
20363 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-107982 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
20379 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5532 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5113 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
345 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-6042 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
272732 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
255099 usd
us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
32705 usd
us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
156483 usd
acan Payments To Acquire Property Plant And Equipment Excluding Construction In Progress
PaymentsToAcquirePropertyPlantAndEquipmentExcludingConstructionInProgress
200000 usd
acan Payments To Acquire Property Plant And Equipment Excluding Construction In Progress
PaymentsToAcquirePropertyPlantAndEquipmentExcludingConstructionInProgress
-0 usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
21717 usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
19854 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-210988 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-136629 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
150000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-150000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-88256 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
118470 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1351094 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
706369 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1262838 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
824839 usd
us-gaap Interest Paid Net
InterestPaidNet
285010 usd
us-gaap Interest Paid Net
InterestPaidNet
284628 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1252871 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1341127 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9967 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9967 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1262838 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1351094 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4210612 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8160427 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7960427 usd
us-gaap Depreciation
Depreciation
225794 usd
us-gaap Depreciation
Depreciation
224961 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19649322 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19758689 usd
CY2022Q3 acan Note Receivable Interest Rate
NoteReceivableInterestRate
0.180 pure
CY2023Q1 acan Note Receivable Interest Rate
NoteReceivableInterestRate
0.180 pure
acan Note Receivable Periodic Payment
NoteReceivablePeriodicPayment
4422 usd
CY2022 acan Note Receivable Periodic Payment
NoteReceivablePeriodicPayment
4422 usd
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
21468 usd
CY2022Q3 us-gaap Notes Receivable Net
NotesReceivableNet
43185 usd
acan Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
196708 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
86622 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
24240 usd
us-gaap Net Income Loss
NetIncomeLoss
109367 usd
us-gaap Net Income Loss
NetIncomeLoss
-508788 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24304886
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24391961
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24391961
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24391961
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24304886
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6980957 usd
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4256869 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6743575 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11735 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P43Y6M
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079 pure
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
170747 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
341500 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
341500 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
341500 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
341500 usd
CY2023Q1 acan Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
13318505 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14855252 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10632905 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
4222347 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11735 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4210612 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
240688 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
234561 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y6M
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M24D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y10M24D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y10M24D
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4026650
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.21
CY2022 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P0Y9M18D
acan Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
-1815000
acan Class Of Warrant Or Right Expired During Period Exercise Price
ClassOfWarrantOrRightExpiredDuringPeriodExercisePrice
1.50
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2211650
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.32
acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P1Y7M6D
CY2023Q1 acan Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
2211650
CY2023Q1 acan Class Of Warrant Or Right Exercisable Exercise Price
ClassOfWarrantOrRightExercisableExercisePrice
1.32
acan Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm
P1Y7M6D

Files In Submission

Name View Source Status
0001437749-23-013846-index-headers.html Edgar Link pending
0001437749-23-013846-index.html Edgar Link pending
0001437749-23-013846.txt Edgar Link pending
0001437749-23-013846-xbrl.zip Edgar Link pending
acan-20230331.xsd Edgar Link pending
acan20230331_10q.htm Edgar Link pending
ex_512637.htm Edgar Link pending
ex_512638.htm Edgar Link pending
ex_512639.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
acan-20230331_cal.xml Edgar Link unprocessable
acan-20230331_def.xml Edgar Link unprocessable
acan-20230331_lab.xml Edgar Link unprocessable
acan-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
acan20230331_10q_htm.xml Edgar Link completed